Podcast Inside Complex Pharma | Ep. 3
Sustainability is not a nice-to-have for us. It is the technical and economic foundation.
In the third episode, we address the question of what role sustainability plays in the pharmaceutical industry today.
Many regard sustainability primarily as a regulatory and bureaucratic burden. In reality, however, it is essential for competitiveness, financial security and a resilient European location.
We are convinced: Those who do not invest in sustainable measures today will face problems tomorrow — not only with the environment, but in the long term also with market viability.
In this episode, we discuss, among other things:
- Why the EU taxonomy is not a bureaucratic add-on, but a strategic and important steering instrument for investments.
- How high GMP standards and green production complement one another.
- What direct (cost) benefits energy efficiency and recyclable packaging bring.
- What role digitalisation and automation play in emissions monitoring.
- Why we must absolutely think about the circular economy and supply security together by 2030. – How we at Complex Pharmaceuticals are implementing state-of-the-art ESG standards in our new production facility and thereby combining ecological responsibility with maximum supply performance
General Manager Christoph Reinwald:
“Sustainability is not a nice-to-have for us. It is the technical and economic foundation for remaining resilient over the long term. Those who invest consistently are securing the future of the location.” Christoph Reinwald, General Manager